Filter
1418
Filtered Results: 1418
Text search:
adverse
drug
event
Featured
Recommendations
181
New Publications
349
Language
Document type
No document type
794
Guidelines
277
Studies & Reports
171
Manuals
87
Strategic & Response Plan
42
Fact sheets
20
Training Material
14
Situation Updates
6
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Online Courses
1
Countries / Regions
India
94
Global
43
Western and Central Europe
40
South Africa
34
Ethiopia
30
Kenya
29
Nigeria
24
Latin America and the Carribbean
23
Ghana
22
Bangladesh
18
Uganda
18
Eastern Europe
18
Nepal
15
Africa
15
Tanzania
15
Sierra Leone
12
Philippines
12
South–East Asia Region
12
Liberia
11
Myanmar / Burma
11
Rwanda
9
Zimbabwe
9
Cambodia
9
Namibia
9
Zambia
9
Malawi
8
USA
8
Colombia
7
Asia
7
Eastern Europe and Central Asia
7
Syria
6
Argentina
6
Brazil
6
Ukraine
5
Western Pacific Region
5
East and Southern Africa
5
Botswana
5
Indonesia
5
Mozambique
4
West and Central Africa
4
Eswatini/ Swaziland
4
Timor Leste/ East Timor
3
Thailand
3
Lesotho
3
Germany
3
Middle East and North Africa
3
South Sudan
3
North Macedonia
2
Tajikistan
2
China
2
Chile
2
Laos
2
Congo, Democratic Republic of
2
Paraguay
2
United Kingdom
2
Bolivia
2
Vietnam
2
Georgia
2
Angola
2
Bhutan
2
North Korea
1
Australia
1
Kazakhstan
1
Cameroon
1
Albania
1
Fiji
1
Kyrgyzstan
1
Bulgaria
1
Guinea
1
Haiti
1
Guinea-Bissau
1
Ireland
1
North America
1
Belarus
1
Lebanon
1
Sri Lanka
1
Russia
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
447
Clinical Guidelines
230
Public Health
92
Women & Child Health
73
Key Resources
46
Pharmacy & Technologies
24
Capacity Building
21
Toolboxes
TB
154
Mental Health
144
HIV
132
COVID-19
80
Pharmacy
73
NTDs
59
AMR
57
Rapid Response
39
NCDs
32
Caregiver
31
Ebola & Marburg
23
Planetary Health
20
Refugee
18
Global Health Education
16
Specific Hazards
14
Conflict
13
Polio
11
Disability
9
Cholera
7
Natural Hazards
6
Zika
4
Health Financing Toolbox
3
Social Ethics
2
Malaria
2
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as technical and programme staff at government institution...
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub...
Medicina 2019, 55, 553; doi:10.3390/medicina55090553
Results: Twenty-one studies were analyzed, most of them demonstrating an association between the existence of burnout and the worsening of patient safety. High levels of burnout is more common among physicians and nurses, and it is associated wit...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
For biological agents, the publication covers 11 bacteria,
fungi and viruses listed by states parties to the Biological
Weapons Convention in declarations of past offensive
research and development programmes, or considered of
special concern for possible use in terrorism. All of these
agents c...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a...
WHO recommends that a...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
(Health Systems in Transition, Vol. 4, No. 3, 2014)
